News
All the news
Tough spring forecast for allergy sufferers
13 03 2025
UAB researcher Jordina Belmonte, head of the Aerobiological Network of Catalonia (XAC) of ICTA-UAB and BABVE, together with Gaspar Dalmau, physician specialising in allergology and president of the Catalan Society of Allergology and Clinical Immunology (SCAIC), presented the forecast of allergenic pollen levels for this spring and the effects they will have on allergy sufferers.
The UAB disables its account on the social network X
26 02 2025
The presence of the UAB in any of the social networks or communication channels of which it makes use does not in any way presuppose sharing the editorial line or other information contained in these networks or channels.
Two cancer research projects of the UAB receive funding from the AECC
26 02 2025
UAB researchers Maria Lluch and Clàudia Faúndez will receive funding from the scientific foundation Associació Espanyola Contra el Càncer (AECC) to develop two projects on glioblastoma and endometrial cancer treatments.
Tetanus Diphtheria Vaccine campaign for those over 40
02 12 2024
The vaccination campaign organised by the UAB Healthcare Service will offer the Tetanus Diphtheria Vaccine to university community member aged over 40.
Project to identify new therapies for Alzheimer's disease receives funding from the Alzheimer's Association
12 11 2024
The Alzheimer’s Association will fund UAB projects studying the molecular alterations of inhibitory neurons which take place in patients with Alzheimer's.
Nanoparticles designed to trap and neutralise large amounts of SARS-CoV2
12 11 2024
Researchers from the IBB-UAB have developed a new class of nanostructures capable of trapping and neutralising large quantities of the SARS-CoV-2 virus particles, both in liquid solutions and on the surface of materials. These novel nanoparticles could be used to manufacture antiviral materials such as wastewater and air filters, and could be exploited to develop new tests for the early detection of COVID-19. Moreover, the nanoparticles could be redesigned to target other pathogens.
UAB researchers cure liver disease MASH by a one-time gene therapy
12 11 2024
UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more than 40 million people. The results were obtained with a single intramuscular administration of the therapeutic viral vectors. The research has also determined that most obese, type 2 diabetic and MASH patients could benefit from the therapy. The results will be the basis for a future clinical trial by the biopharmaceutical company Kriya
Autumn vaccination campaign 2024
16 09 2024
As every year, the flu vaccination campaign begins in the fall. As it was done in past seasons, this year it will also be carried out in conjunction with the vaccination against COVID-19.
Five tips to prevent respiratory diseases
16 09 2024
Wash your hands frequently. Use disposable tissues when coughing or sneezing. Put on the mask covering your nose and mouth. Ventilate closed spaces. Get a flu shot if you're 60 or older, have a chronic illness, or are pregnant.
WHO Laboratory Biosecurity Guidance document
26 06 2024
WHO publishes revised "Laboratory Biosecurity Guidance".